Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

All financial results are reported in Canadian dollars, unless otherwise stated.

MONTREAL, July 28, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its financial and operating results for the three and nine-month periods ended May 31, 2025.

Read more at globenewswire.com